Christine C Rogers

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “ASO Author Reflections: Neoadjuvant Systemic Therapy and Nodal Management in cT1-2 N0 Triple-Negative Breast Cancer”.

ASO Author Reflections: Neoadjuvant Systemic Therapy and Nodal Management in cT1-2 N0 Triple-Negative Breast Cancer

Annals of Surgical Oncology(2024)10.1245/s10434-024-15020-6

N/A

0DataRank · unranked

3 citations

Christine C Rogers, Mediget Teshome, Chandler S. Cortina

National trends in neoadjuvant systemic therapy utilization in patients with early-stage HER2-positive breast cancer from 2016–2021: The impact of the KATHERINE trial

Breast Cancer Research and Treatment(2025)10.1007/s10549-025-07750-2

N/A

0DataRank · unranked

5 citations

Christine C Rogers, Jan Irene Lloren, Sailaja Kamaraju, Lubna N. Chaudhary, Chiang‐Ching Huang +6 more

Does neoadjuvant systemic therapy in clinical T1–2 N0 human epidermal growth factor receptor 2–positive breast cancer increase the extent of axillary surgery?

Surgery(2025)10.1016/j.surg.2025.109907

N/A

0DataRank · unranked

0 citations

Lauren N. Cohen, Jan Irene Lloren, Chiang‐Ching Huang, Adrienne N. Cobb, Amanda L. Kong +4 more